Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06693960 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 15, 2025 to Dec 15, 2026
    • Study completion date: Dec 31, 2025 to Jan 31, 2027
    v3
  2. Primary endpoint revised
    • Secondary endpoints revised (14)
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to determine how the supplement oregano affects how the body metabolizes pharmaceutical drugs.
Trial Details
NCT Number NCT06693960
Lead Sponsor Washington State University
Collaborators: Office of Dietary Supplements (ODS), National Center for Complementary and Integrative Health (NCCIH)
Conditions
(from sponsor)		 Interaction
Enrollment 16 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov